Glutathione
Glutathione
Glutathione is a useful contrast case because it is widely available, clinically familiar, and much easier for compliant pharmacies to defend.
Current status
Legal
Antioxidant-related interest, with current federal compounding constraints still in play.
FDA category
USP Monograph
Can pharmacies compound this?
Yes
Reclassification expected?
Unclear
Unlike the restricted peptides, glutathione already sits inside a normal access pattern.
Primary Use
Antioxidant-related interest
Regulatory Timeline
Feb 27, 2026
Political pressure and market expectations increased around a future peptide reclassification review.
Jul 1, 2025
Ingredient remained available through approved or established compounding pathways.
Mar 15, 2023
FDA peptide compounding scrutiny intensified across 503A and 503B channels.
Get notified...
Get notified when Glutathione status changes
State-specific notes
Florida
Remains broadly accessible through wellness practices.